ESMO Calls for Oncology-Specific Safeguards in the EU Critical Medicines Act By Ogkologos - June 11, 2025 453 0 Facebook Twitter Google+ Pinterest WhatsApp Ensuring equitable access to cancer treatments remains central to EU health security efforts Source RELATED ARTICLESMORE FROM AUTHOR ESMO’s Special Consultative Status with United Nations Economic and Social Council (UN ECOSOC) Confirmed Until 2028 EMA Recommends Extension of Indications for Selumetinib ESMO Calls for Urgent Changes to the in Vitro Diagnostic Medical Devices Regulation (IVDR) in Order to Safeguard Cancer Research in Europe MOST POPULAR The ecDNA story – catching the mastermind behind cancer evolution February 20, 2023 New Year’s Wishes 2016 December 29, 2022 Happy Occupational Therapy Month April 19, 2023 How CRISPR is Changing Cancer Research and Treatment July 27, 2020 Load more HOT NEWS Diagnosed Alone Cancer “Liquid Biopsy” Blood Test Gets Expanded FDA Approval Inavolisib Plus Palbociclib-Fulvestrant Prolongs OS in Patients with PIK3CA-Mutated Advanced Breast Cancer Using Aspirin to Prevent Breast Cancer Recurrence and Targeted Therapy for...
